ARIXTRA - 0007-3230-02 - (fondaparinux sodium)

Alphabetical Index


Drug Information of ARIXTRA

Product NDC: 0007-3230
Proprietary Name: ARIXTRA
Non Proprietary Name: fondaparinux sodium
Active Ingredient(s): 2.5    mg/.5mL & nbsp;   fondaparinux sodium
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ARIXTRA

Product NDC: 0007-3230
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021345
Marketing Category: NDA
Start Marketing Date: 20050330

Package Information of ARIXTRA

Package NDC: 0007-3230-02
Package Description: 2 SYRINGE in 1 CARTON (0007-3230-02) > .5 mL in 1 SYRINGE (0007-3230-01)

NDC Information of ARIXTRA

NDC Code 0007-3230-02
Proprietary Name ARIXTRA
Package Description 2 SYRINGE in 1 CARTON (0007-3230-02) > .5 mL in 1 SYRINGE (0007-3230-01)
Product NDC 0007-3230
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name fondaparinux sodium
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20050330
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name FONDAPARINUX SODIUM
Strength Number 2.5
Strength Unit mg/.5mL
Pharmaceutical Classes Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA]

Complete Information of ARIXTRA


General Information